145 related articles for article (PubMed ID: 38602577)
1. ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.
Ślusarczyk A
Ann Surg Oncol; 2024 Jun; 31(6):3910-3911. PubMed ID: 38602577
[No Abstract] [Full Text] [Related]
2. ASO Visual Abstract: Changes in the Urinary Microbiome following Transurethral Resection of Non-muscle-invasive Bladder Cancer-Insights from a Prospective Observational Study.
Ślusarczyk A; Ismail H; Zapała Ł; Piecha T; Zapała P; Radziszewski P
Ann Surg Oncol; 2024 Jul; 31(7):4811. PubMed ID: 38671289
[No Abstract] [Full Text] [Related]
3. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
Richards KA; Smith ND; Steinberg GD
J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
[TBL] [Abstract][Full Text] [Related]
4. Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer.
Das A; Cohen JE; Ko OS; Jordan BJ; Glaser AP; Auffenberg GB; Meeks JJ
J Urol; 2021 Mar; 205(3):693-700. PubMed ID: 33021430
[TBL] [Abstract][Full Text] [Related]
5. Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.
Blute ML; Rushmer TJ; Shi F; Fuller BJ; Abel EJ; Jarrard DF; Downs TM
J Urol; 2015 Nov; 194(5):1214-9. PubMed ID: 26173101
[TBL] [Abstract][Full Text] [Related]
6. A commentary on 'systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer' (Int J Surg 2022; 104:106777).
Tan Z; Wang H; Wang J
Int J Surg; 2023 Feb; 109(2):208-210. PubMed ID: 36799855
[No Abstract] [Full Text] [Related]
7. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
[TBL] [Abstract][Full Text] [Related]
8.
Yanagisawa T; Mori K; Motlagh RS; Kawada T; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; D'Andrea D; Compérat E; Miki J; Kimura T; Egawa S; Shariat SF
J Urol; 2022 Apr; 207(4):754-768. PubMed ID: 35060770
[TBL] [Abstract][Full Text] [Related]
9. Indication for early cystectomy in nonmuscle-invasive bladder cancer. Literature review.
Cogorno Wasylkowski L; Ríos-González E; Linares Espinós E; Leibar Tamayo A; Martínez-Piñeiro Lorenzo L
Actas Urol Esp (Engl Ed); 2018; 42(1):17-24. PubMed ID: 28238343
[TBL] [Abstract][Full Text] [Related]
10. Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project.
Hurle R; Lazzeri M; Vanni E; Lughezzani G; Buffi N; Casale P; Saita A; Morenghi E; Forni G; Cardone P; Lista G; Colombo P; Peschechera R; Pasini L; Zandegiacomo S; Benetti A; Maffei D; Vavassori I; Guazzoni G
J Urol; 2018 Feb; 199(2):401-406. PubMed ID: 28847481
[TBL] [Abstract][Full Text] [Related]
11. Editorial Comment from Dr Tellini et al. to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Tellini R; Mari A; Minervini A
Int J Urol; 2022 Jul; 29(7):640. PubMed ID: 35384083
[No Abstract] [Full Text] [Related]
12. Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Hayakawa N; Kikuchi E
Int J Urol; 2022 Jul; 29(7):639-640. PubMed ID: 35368133
[No Abstract] [Full Text] [Related]
13. Editorial Comment from Dr Naselli and Dr Pirola to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Naselli A; Pirola GM
Int J Urol; 2022 Jul; 29(7):638-639. PubMed ID: 35362114
[No Abstract] [Full Text] [Related]
14. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.
Audenet F; Waingankar N; Ferket BS; Niglio SA; Marqueen KE; Sfakianos JP; Galsky MD
J Urol; 2018 Nov; 200(5):996-1004. PubMed ID: 29879397
[TBL] [Abstract][Full Text] [Related]
16. Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer.
Zehnder P; Thalmann GN
Curr Opin Urol; 2013 Sep; 23(5):423-8. PubMed ID: 23880740
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.
Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B
Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).
Prasad SM; Huang WC; Shore ND; Hu B; Bjurlin M; Brown G; Genov P; Shishkov D; Khuskivadze A; Ganev T; Marchev D; Orlov I; Kopyltsov E; Zubarev V; Nosov A; Komlev D; Burger B; Raju S; Meads A; Schoenberg M
J Urol; 2023 Oct; 210(4):619-629. PubMed ID: 37548555
[TBL] [Abstract][Full Text] [Related]
19. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
Herr HW; Donat SM; Dalbagni G
J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
[TBL] [Abstract][Full Text] [Related]
20. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
